Insights from 2023 ASCO® Annual Meeting

 

Insights from 2023 ASCO® Annual Meeting
A

ASCO® 2023 Insights: "Post Hoc Analysis of Patients With Nonviral Etiology From REFLECT Trial - Efficacy of Lenvatinib vs. Sorafenib in the 1L Treatment of Patients With Unresectable HCC"

By Insights from 2023 ASCO® Annual Meeting FEATURING Ari Baron
By Insights from 2023 ASCO® Annual Meeting FEATURING Ari Baron
63 views
July 17, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

21:17
Janssen Oncology

The Man Cave

Feat. J. Hamilton, M. Fabrizio, M. Taha
GI
05:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Post Hoc Analysis of Patients With Nonvir…

Feat. A. Baron
05:51
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KEYNOTE-859 Study of Pembro + Chemo for A…

Feat. S. Rha
08:16
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary Results From the Multicenter, Ran…

Feat. K. Raghav
08:56
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Survival Outcomes of the Randomized…

Feat. Y. Kang
05:54
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 PANOVA-3 Study - TTF Therapy Conc…

Feat. H. Babiker
05:58
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 STELLAR-303 Study - XL092 in Comb…

Feat. J. Hecht
04:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Alliance A021806 Data on Perioperative vs…

Feat. A. Chawla, C. Ferrone
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
11:32
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Perioperative PD-1 Antibody Toripalimab +…

Feat. S. Yuan
02:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Analysis of SUNLIGHT Trial on Trifluridin…

Feat. J. Taieb
10:43
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "FGFR 2.0 in BTC - Is There a Best in Clas…

Feat. A. Vogel
07:21
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KRYSTAL-1 Trial - Activity & Safety o…

Feat. S. Pant
09:14
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results From the Pivotal Phase 2b HERIZON…

Feat. S. Pant
06:32
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "STAR-221 Phase 3 Trial - Domvanalimab, Zi…

Feat. S. Klempner
09:13
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The Randomized Phase 3 CAIRO4 Study of th…

Feat. D. Van Der Kruijssen
06:05
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results From the GALAXY Study in …

Feat. E. Oki
11:09
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 2 Basket Study of Tucatinib &…

Feat. Y. Nakamura
10:09
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The NeoCol Phase III Randomized Clinical …

Feat. L. Henrik Jensen
06:26
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "64-Month Follow-Up From CheckMate 142 - 1…

Feat. H. Lenz
11:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Bas…

Feat. S. Stintzing
08:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 ATTRACTION-5 Study - Nivo + Chemo…

Feat. M. Terashima
11:05
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy, Safety, & PROs From the Pha…

Feat. M. Kudo
04:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Biomarker Analysis of 2 Zolbetuximab Phas…

Feat. K. Shitara
22:55
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…

Feat. R. Kim, R. Mehta